Since mitochondria play a key role in the fibrotic processes in PDA, high expression of SPRR3 may sensitize HPAF-II cells lacking CEACAM6 to DNA damage-induced apoptosis via the loss of mitochondrial outer membrane potential (MOMP). The gene discussed is SPRR3; the disease is Patent ductus arteriosus.